Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone Influenza Virus Vaccine (2008-2009 Formulation).
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi
- 02 Mar 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Actual patient numbers (32) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.